Urinary dysfunction (e.g., frequency, urgency, incontinence) Sexual dysfunction (erectile dysfunction) Postoperative pain and fatigue Reduced quality of life
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male patients aged = 18 years; 2.Pathologically confirmed diagnosis of prostate adenocarcinoma prior to surgery, with a planned radical prostatectomy; 3.Availability of complete preoperative clinical data, including serum prostate-specific antigen (PSA), imaging examinations (e.g., MRI, ultrasound), and physical examination records; 4.Willingness and ability to participate in follow-up both before and after surgery, including completion of quality-of-life questionnaires and functional assessments; 5.Ability to provide written informed consent and voluntary participation in this study.
Exclusion criteria
Exclusion criteria: 1.Patients with confirmed advanced or metastatic prostate cancer; 2.Patients who have previously received prostate cancer-related treatments (e.g., endocrine therapy, radiotherapy, surgery); 3.Patients with severe organ dysfunction, autoimmune diseases, or psychiatric disorders that make them unsuitable for participation; 4.Inability to obtain imaging data or biological specimens, or incomplete clinical data; 5.Patients unwilling or unable to complete study follow-up and data collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary continence recovery;Quality of life score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Erectile function recovery; | — |
Countries
China
Contacts
Zhejiang Provincial People's Hospital